Table 1 Participant characteristics at baseline and endpoint.
Variable | Baseline | After 52 weeks | Paired t or χ2 | p |
|---|---|---|---|---|
Cases (n) | 106 | 41 | ||
Age (years, mean ± SD) | 36.3 ± 9.6 | 39.7 ± 10.2 | – | – |
Sex (male/female) | 98/8 | 39/2 | – | – |
Education (years, mean ± SD) | 12.6 ± 2.9 | 12.7 ± 2.8 | ||
Disease duration (years, mean ± SD) | 6.5 ± 7.3 | 7.7 ± 7.9 | – | – |
Psychiatric comorbidities (n/%) | – | – | ||
Yes | 60 (56.6) | – | – | – |
No | 46 (43.4) | – | – | – |
Mood disorders (n/%) | – | – | ||
Yes | 37 (34.9) | – | – | – |
No | 69 (65.1) | – | – | – |
Anxiety disorder (n/%) | – | – | ||
Yes | 18 (17.0) | – | – | – |
No | 88 (83) | – | – | – |
Psychotic disorder (n/%) | ||||
Yes | 8 (7.5) | – | ||
No | 98 (92.5) | – | ||
Other SUD (n/%) | – | – | ||
Yes | 41 (38.7) | – | – | – |
No | 65 (61.3) | – | – | – |
ASPD (n/%) | – | – | ||
Yes | 12 (11.3) | – | – | – |
No | 94 (88.7) | – | – | – |
Urine methamphetamine (n/%) | 114.6 | 0.007 | ||
Positive | 25 (23.6) | 2 (5.0) | – | – |
Negative | 81 (76.4) | 26 (63) | – | – |
Loneliness (mean ± SD) | 43.3 ± 10.3 | – | – | – |
TPQ-HA (mean ± SD) | 14.4 ± 5.4 | – | – | – |
TPQ-NS (mean ± SD) | 16.0 ± 4.2 | – | – | – |
MSF (mean ± SD) | 102.1 ± 18.2 | – | – | – |
HDRS (mean ± SD) | 5.4 ± 4.2 | – | – | – |
APGAR (mean ± SD) | 12.5 ± 4.8 | – | – | – |
VAS (mean ± SD)# | 13.2 ± 21.0 | 9.8 ± 18.1 | 2.27 | 0.03 |
